Lusutrombopag Is a Safe and Efficacious Treatment Option for Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Invasive Procedures: A Pooled Analysis of Two Phase 3 Trials

被引：0
|
作者：
Brown, Robert S., Jr. [1 ]
Imawari, Michio [2 ]
Izumi, Namiki [3 ]
Osake, Yukio [4 ]
Ochiai, Toshimitsu [5 ]
Kano, Takeshi [5 ]
Bentley, Roy [6 ]
Peck-Radosavljevic, Markus [7 ]
机构：
[1] Weill Cornell Med Coll, New York, NY USA
[2] Shin Yurigaoka Gen Hosp, Kawasaki, Kanagawa, Japan
[3] Japanese Red Cross Soc Musashino Hosp, Musashino, Tokyo, Japan
[4] Meiwa Hosp, Nishinomiya, Hyogo, Japan
[5] Shionogi & Co Ltd, Osaka, Japan
[6] Shionogi Inc, Florham Pk, NJ USA
[7] Klinikum Klagenfurt Am Worthersee, Klagenfurt Am Worthersee, Austria
来源：
HEPATOLOGY | 2018年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2016
引用
收藏
页码：1148A / 1148A
页数：1
相关论文
共 50 条
  • [21] Real-world data demonstrate safety and effectiveness of lusutrombopag in chronic liver disease patients with thrombocytopenia undergoing planned invasive procedures: Interim analysis
    Afdhal, Nezam
    Shiino, Chikako
    Sasaki, Ritsue
    Bentley, Roy
    Cai, Bin
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E626 - E626
  • [22] Is platelet monitoring during 7-day lusutrombopag treatment necessary in chronic liver disease patients with thrombocytopenia undergoing planned invasive procedures? A phase IIIb open-label study
    Numata, Kazushi
    Tanaka, Katsuaki
    Katsube, Takayuki
    Ochiai, Toshimitsu
    Fukuhara, Takahiro
    Kano, Takeshi
    Osaki, Yukio
    Izumi, Namiki
    Imawari, Michio
    [J]. HEPATOLOGY RESEARCH, 2020, 50 (10) : 1141 - 1150
  • [23] Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study
    Hiroaki Nomoto
    Naoki Morimoto
    Kouichi Miura
    Shunji Watanabe
    Yoshinari Takaoka
    Hiroshi Maeda
    Takahiro Sasaki
    Yohei Koyashiki
    Hidekazu Kurata
    Norikatsu Numao
    Norio Isoda
    Hironori Yamamoto
    [J]. BMC Gastroenterology, 20
  • [24] Lusutrombopag is effective and safe in patients with chronic liver disease and severe thrombocytopenia: a multicenter retrospective study
    Nomoto, Hiroaki
    Morimoto, Naoki
    Miura, Kouichi
    Watanabe, Shunji
    Takaoka, Yoshinari
    Maeda, Hiroshi
    Sasaki, Takahiro
    Koyashiki, Yohei
    Kurata, Hidekazu
    Numao, Norikatsu
    Isoda, Norio
    Yamamoto, Hironori
    [J]. BMC GASTROENTEROLOGY, 2020, 20 (01)
  • [25] COMPARATIVE EFFICACY AND SAFETY OF AVATROMBOPAG VERSUS LUSUTROMBOPAG IN PATIENTS WITH CHRONIC LIVER DISEASE AND SEVERE THROMBOCYTOPENIA UNDERGOING INVASIVE PROCEDURES: A SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS
    Wojciechowski, P.
    Wilson, K.
    Pochopien, M.
    Pustulka, I
    Smela, B.
    Tytula, A.
    Vredenburg, M.
    Nazir, J.
    [J]. VALUE IN HEALTH, 2021, 24 : S84 - S84
  • [26] A Phase 3, Randomized, Double-blind, Placebo-controlled Study of Lusutrombopag for Thrombocytopenia in Patients with Chronic Liver Disease Undergoing Elective Invasive Procedures in Japan (L-PLUS 1)
    Izumi, Namiki
    Osaki, Yukio
    Yamamoto, Kazuhide
    Kurokawa, Mineo
    Tanaka, Katsuaki
    Kano, Takeshi
    Fukuhara, Takahiro
    Ochiai, Toshimitsu
    Imawari, Michio
    [J]. HEPATOLOGY, 2015, 62 (06) : 1397A - 1398A
  • [27] A cost-effectiveness analysis of lusutrombopag for thrombocytopenia in patients with chronic liver disease in Japan
    Miki, Norikane
    Inoue, Sachie
    Shibahara, Hidetoshi
    Kurazono, Kenji
    Perard, Rodolphe
    Tateishi, Ryosuke
    [J]. JGH OPEN, 2021, 5 (08): : 879 - 887
  • [28] Safety and effectiveness of lusutrombopag in patients who have chronic liver disease with thrombocytopenia and undergoing invasive procedures: Real-world post-marketing surveillance in Japan
    Yoshiji, Hitoshi
    Suzuki, Junto
    Imasaki, Masafumi
    Tsukimura, Eri
    Miyano, Makiko
    Kurosaki, Masayuki
    [J]. HEPATOLOGY RESEARCH, 2023, 53 (11) : 1105 - 1116
  • [29] EFFICACY OF ORAL THROMBOPOIETIN RECEPTOR AGONIST LUSUTROMBOPAG IN CHRONIC LIVER DISEASE PATIENTS UNDERGOING A GASTROINTESTINAL PROCEDURE: RESULTS FROM TWO PHASE 3 CLINICAL TRIALS
    Moehlen, Martin
    Semaan, Mark
    Kano, Takeshi
    Ochiai, Toshimitsu
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S614 - S614
  • [30] Clinical Relevance of Thrombocytopenia in Patients With Advanced Liver Disease Undergoing Invasive Procedures
    Giannini, Edoardo G.
    Greco, Alfredo
    Andorno, Enzo
    Valente, Umberto
    Savarino, Vincenzo
    [J]. GASTROENTEROLOGY, 2010, 138 (05) : S819 - S819
12345